ARGERIS N KARABELAS Insider Trading
Get free email notifications about insider trading for ARGERIS N KARABELAS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARGERIS N KARABELAS. ARGERIS N KARABELAS is a Director in Valeant Pharmaceuticals International, Inc. ($BVF) and a Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and a in REGENXBIO Inc. ($RGNX) and a Director in REGENXBIO Inc. ($RGNX).
Address: C/O ANADYS PHARMACEUTICALS, INC. 9050 CAMINO SANTA FE SAN DIEGO 92121 CA
Companies in which ARGERIS N KARABELAS is an Insider
Bausch Health Companies Inc.
Trading Symbol: BVFIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARGERIS N KARABELAS: Director
Holdings: 89,328 shares
Latest Transaction: May 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REGENXBIO Inc.
Trading Symbol: RGNXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ARGERIS N KARABELAS:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 02 2020
$RGNX Market Capitalization: $465.96M
$RGNX Previous Close: $17.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ROCKET PHARMACEUTICALS, INC.
Trading Symbol: RCKTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARGERIS N KARABELAS: Director
Holdings: 2,277,139 shares
Current Value: $3,871,136
Latest Transaction: Jun 26 2015
$RCKT Market Capitalization: $44.43M
$RCKT Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ARGERIS N KARABELAS
Sentiment: All, BVF, RGNX, RCKT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | BVF | Bausch Health Comp ... | KARABELAS ARGERIS N | Director | Grant | A | 0.00 | 7,645 | 0 | 89,328 | 81.7 K to 89.3 K (+9.36 %) |
Jun 02 2020 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
Jun 04 2019 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
May 03 2019 | BVF | Bausch Health Comp ... | KARABELAS ARGERIS N | Director | Grant | A | 23.51 | 10,633 | 249,982 | 70,646 | 60 K to 70.6 K (+17.72 %) |
May 30 2018 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
May 04 2018 | BVF | Valeant Pharmaceut ... | KARABELAS ARGERIS N | Director | Grant | A | 0.00 | 14,285 | 0 | 60,417 | 46.1 K to 60.4 K (+30.97 %) |
May 26 2017 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Director | Option Exercise | A | 18.85 | 12,500 | 235,625 | 12,500 |